CompletedPhase 2NCT02949791
HIPEC Using High Intra-abdominal Pressure
Studying Pseudomyxoma peritonei
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Principal Investigator
- Shigeki Kusamura, MD PhDFondazione IRCCS Istituto Nazionale dei Tumori di Milano
- Intervention
- Cytoreductive surgery(procedure)
- Enrollment
- 38 target
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2014 – 2017
Study locations (1)
- Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, MI, Italy
Collaborators
Associazione Italiana per la Ricerca sul Cancro
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02949791 on ClinicalTrials.govOther trials for Pseudomyxoma peritonei
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07328737One vs Three HIPEC Cycles After CRS for Pseudomyxoma PeritoneiBeijing Tsinghua Chang Gung Hospital
- RECRUITINGEARLY PHASE1NCT07341360Pseudovax - A Cancer Vaccine for Patients With Pseudomyxoma PeritoneiOslo University Hospital
- RECRUITINGNCT02073500Peritoneal Surface Malignancies - Characterization, Models and Treatment StrategiesOslo University Hospital